INTEGRATED BIOPHARMA INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Integrated Biopharma Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q4 2011 to Q3 2024.
  • Integrated Biopharma Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 30.1M shares, a 0.45% increase year-over-year.
  • Integrated Biopharma Inc annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 30.1M shares, a 0.39% increase from 2023.
  • Integrated Biopharma Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 29.9M shares, a 0.36% increase from 2022.
  • Integrated Biopharma Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 29.8M shares, a 0.49% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 30.1M +134K +0.45% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 30.1M +116K +0.39% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-20
Q1 2024 30.1M +150K +0.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 30.1M +150K +0.5% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-12
Q3 2023 30M +16.3K +0.05% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 29.9M +106K +0.36% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-20
Q1 2023 29.9M +128K +0.43% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 29.9M +126K +0.42% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-12
Q3 2022 29.9M +132K +0.44% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 29.8M +144K +0.49% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-15
Q1 2022 29.8M +111K +0.37% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 29.8M +165K +0.56% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q3 2021 29.8M +172K +0.58% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 29.7M +127K +0.43% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-13
Q1 2021 29.7M +144K +0.49% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 29.7M +92.7K +0.31% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 29.6M +80K +0.27% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 29.6M +642K +2.22% Apr 1, 2020 Jun 30, 2020 10-K 2021-09-02
Q1 2020 29.6M 0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 29.6M +174K +0.59% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-12
Q3 2019 29.6M +2.35M +8.62% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 28.9M +7.8M +36.9% Apr 1, 2019 Jun 30, 2019 10-K 2020-09-23
Q1 2019 29.6M +8.43M +39.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 29.4M +8.26M +39.1% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-12
Q3 2018 27.2M +6.08M +28.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 21.1M Apr 1, 2018 Jun 30, 2018 10-K 2019-08-29
Q1 2018 21.1M +9.22K +0.04% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 21.1M +29.1K +0.14% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-13
Q3 2017 21.1M +30K +0.14% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q1 2017 21.1M +20.8K +0.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 21.1M +924 +0% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 21.1M 0 0% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q1 2016 21.1M 0 0% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 21.1M 0 0% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-10
Q3 2015 21.1M 0 0% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 21.1M +23.2K +0.11% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-02
Q1 2015 21.1M +25K +0.12% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 21.1M +25K +0.12% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-19
Q3 2014 21.1M +25K +0.12% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 21.1M Apr 1, 2014 Jun 30, 2014 10-K 2015-09-04
Q1 2014 21.1M 0 0% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 21.1M 0 0% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 21.1M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q1 2013 21.1M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 21.1M +93.4K +0.45% Oct 1, 2012 Dec 31, 2012 10-Q/A 2014-02-13
Q4 2011 21M Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.